NBY
EquityNovaBay Pharmaceuticals, Inc.
Health Care · Biotechnology
$1.43
+1.43 (+0.00%)
Open
N/A
Day Range
$1.30 - $1.70
52W Range
$1.30 - $99.75
Volume
454K
Price History
Key Statistics
Market Cap
N/A
P/E Ratio
N/A
EPS
N/A
Dividend Yield
N/A
P/B Ratio
N/A
Payout Ratio
N/A
ROE
N/A
Debt/Equity
N/A
Insider Activity
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 21, 2025 |
R01 FUND L.P. Beneficial Owner of more than 10% of a Class of Security |
Other | 56,806,080 | - |
| Oct 21, 2025 |
KAZLEY MICHAEL JOHN Chief Executive Officer |
Other | 56,806,080 | - |
| Oct 21, 2025 |
LAZAR DAVID ELLIOT Beneficial Owner of more than 10% of a Class of Security |
Exercise | 6,388,000 | $632.9M |
| Oct 21, 2025 |
LAZAR DAVID ELLIOT Beneficial Owner of more than 10% of a Class of Security |
Other | 6,388,000 | - |
| Oct 21, 2025 |
R01 FUND L.P. Beneficial Owner of more than 10% of a Class of Security |
Other | 56,806,080 | - |
| Oct 21, 2025 |
LAZAR DAVID ELLIOT Beneficial Owner of more than 10% of a Class of Security |
Other | 6,388,000 | - |
| Oct 21, 2025 |
KAZLEY MICHAEL JOHN Chief Executive Officer |
Other | 56,806,080 | - |
| Oct 21, 2025 |
LAZAR DAVID ELLIOT Beneficial Owner of more than 10% of a Class of Security |
Exercise | 6,388,000 | $632.9M |
| Oct 21, 2025 |
FRAMEWORK VENTURES IV L.P. Beneficial Owner of more than 10% of a Class of Security |
Other | 56,806,080 | - |
| Oct 21, 2025 |
FRAMEWORK VENTURES IV L.P. Beneficial Owner of more than 10% of a Class of Security |
Other | 56,806,080 | - |
Institutional Ownership
| Holder | Shares | % Held | Value |
|---|---|---|---|
| Blackrock Inc. | 366,146 | 0.28% | $527.3K |
| Vanguard Group Inc | 365,845 | 0.28% | $526.8K |
| Geode Capital Management, LLC | 251,541 | 0.19% | $362.2K |
| State Street Corporation | 62,741 | 0.05% | $90.3K |
| Northern Trust Corporation | 54,758 | 0.04% | $78.9K |
| Goldman Sachs Group Inc | 20,868 | 0.02% | $30.0K |
| Charles Schwab Investment Management, Inc. | 18,652 | 0.01% | $26.9K |
| Jane Street Group, LLC | 14,014 | 0.01% | $20.2K |
| Susquehanna International Group, LLP | 9,349 | 0.01% | $13.5K |
| C2c Wealth Management, LLC | 9,000 | 0.01% | $13.0K |
Latest News
Top Midday Decliners
NovaBay Pharmaceuticals Reports At-The-Market Equity Program
Assessing NovaBay Pharmaceuticals’ (NBY) Valuation After A Sharp Short Term Share Price Surge
Wall Street Set to Open Little Changed as Investors Await Home Sales, Consumer Sentiment Data
Fair Value Estimate
DDM Value
$84.00
Growth: 5.0% | Req. return: 10%
Peers in Health Care
| Symbol | Name | Price | Mkt Cap | Div Yield | Change |
|---|---|---|---|---|---|
| ABT | Abbott Laboratories | $116.35 | N/A | 2.06% | +0.00% |
| ABCL | AbCellera Biologics Inc. | $3.61 | N/A | - | +0.00% |
| ACAD | ACADIA Pharmaceuticals Inc. | $24.56 | N/A | - | +0.00% |
| AKBA | Akebia Therapeutics, Inc. | $1.31 | N/A | - | +0.00% |
| 001540.KQ | AHN-GOOK PHA | $8,070.00 | N/A | 5.45% | +0.00% |
| A | Agilent Technologies, Inc. | $121.38 | N/A | 0.82% | +0.00% |
| ABBV | AbbVie Inc. | $232.08 | N/A | 2.87% | +0.00% |
| AHCO | AdaptHealth Corp. | $9.15 | N/A | - | +0.00% |
About NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc. manufactures and sells wound care products. The company offers hypochlorous acid for use in the cleansing and irrigation of post-surgical wounds, minor burns, and superficial abrasions. It sells its products to its distribution partners in China. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
novabay.com →🐂 Bull Score
Our proprietary rating measures dividend reliability based on 6 fundamental factors including payout sustainability, financial strength, and cash flow coverage.
Very Risky
Bull Score
Dividend Safety
Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.
Unsafe
Based on 4 fundamental factors
Analysis Tools
Share
Dividend History
🐂 Bull Score
Our proprietary rating measures dividend reliability based on 6 fundamental factors including payout sustainability, financial strength, and cash flow coverage.
Very Risky
Bull Score
Dividend Safety
Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.
Unsafe
Based on 4 fundamental factors
Loading financial data...
Revenue & Earnings
No financial statement data available for NBY.